CCL2 and hepatocellular carcinoma: Here, we report the identification of two novel serum biomarkers, namely prolactin and monocyte chemoattractant protein-1 (MCP-1) that were significantly elevated in patients with resectable HCC compared to non-HCC chronic hepatitis B (HBV) carriers.